Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Alibaba Earnings: BABA Stock Ticks 2% Lower Despite Q1 Beats

By Nick Clarkson, Web Editor Aug 20, 2020

Alibaba earnings on Thursday morning have BABA stock lower despite the company beating Wall Street's estimates for EPS and revenue.

Inovio Becomes a Covid-19 Longshot

By Dana Blankenhorn, InvestorPlace Contributor Aug 20, 2020

No one knows which of the many vaccine candidates will be safe and effective, but Inovio's unique approach has left it without a major manufacturing contract.

7 Battery Stocks for High-Powered Gains

By Chris Lau, InvestorPlace Contributor Aug 20, 2020

Lithium-ion batteries are benefiting from the massive growth in electric car production. Which are the best battery stocks to buy?

Hit the Brakes on Ford Stock for Now, But Buy It on Any Weakness

By Thomas Niel, InvestorPlace Contributor Aug 20, 2020

Granted, F stock could rally in the next few years. But, in the short-term, it may be time to hit the brakes.

SPAQ Stock Is A Risky Investment At This Point

By Tezcan Gecgil, InvestorPlace Contributor Aug 20, 2020

SPAQ stock is not as appealing as an EV play now that a proposed reverse merger with Fisker has been delayed until next year.

IBIO Stock Is Likely Done in the Covid-19 Race

By Alex Sirois, InvestorPlace Contributor Aug 20, 2020

IBIO stock has continued its volatile swings, this time for the worse. Despite seemingly positive sentiment, it is too far behind to win.

Telehealth Services Set to Grow in Wake of Pandemic

By Robert Lakin, InvestorPlace Contributor Aug 20, 2020

NYU Langone Health reported urgent virtual telehealth visits increasing by 683% between March and April 2020.

Why Nio Stock Will Stop Falling Soon

By Chris Lau, InvestorPlace Contributor Aug 20, 2020

Nio stock is down on profit-taking for now, so as selling pressure eases, investors will focus on its strong fundamentals again.

Transportation 2.0: Automakers and Tech Companies Converge

By InvestorPlace Research Staff Aug 19, 2020

As the world moves into Transportation 2.0, hold onto your seat and own shares in the companies leading these revolutions converging at the same.

XpresSpa Group Earnings: XSPA Stock Grows 6% on Q2 Results

By William White, InvestorPlace Writer Aug 19, 2020

XpresSpa Group (XSPA) earnings for the health and wellness company's second quarter of 2020 have XSPA stock soaring higher after-hours Wednesday.

Nvidia Earnings: NVDA Stock Dips 1% Lower Despite Q2 Earnings Beat

By William White, InvestorPlace Writer Aug 19, 2020

Nvidia (NVDA) earnings for the graphics card company's fiscal second quarter of 2021 have NVDA stock dipping lower after-hours Wednesday.

L Brands Earnings: LB Stock Jumps 3% on Surprise Positive EPS

By William White, InvestorPlace Writer Aug 19, 2020

L Brands (LB) earnings for the owner of Bath & Body Works' second quarter of 2020 have LB stock on the rise after-hours Wednesday.

Will ‘Cancel Culture’ Hurt Penn National Gaming Stock?

By Josh Enomoto, InvestorPlace Contributor Aug 19, 2020

At first glance, Penn National Gaming’s partnership with the controversial Barstool Sports appears troubling for PENN stock. Here’s the surprising reason why it doesn’t matter.

Costco Is a Great Company, But an Expensive Stock

By Ian Bezek, InvestorPlace Contributor Aug 19, 2020

Costco remains a compelling growth company. However, Costco stock has run too far too fast and is vulnerable to a pullback this fall.

Plug Power News: Why PLUG Stock Is Powering Up 7% Today

By William White, InvestorPlace Writer Aug 19, 2020

Plug Power (PLUG) is in the news Wednesday after announcing a new hydrogen fuel cell system for use in small aerospace robotics.

Novavax Is the Ultimate Coronavirus Stock

By Dana Blankenhorn, InvestorPlace Contributor Aug 19, 2020

Novavax has failed at late-stage clinical trials before, but if its COVID-19 vaccine even has 50% efficacy it could open up a huge global opportunity.